Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248772 | 7849410 | F | 8248772-2 | 20120326 | 20120331 | EXP | PHHY2011CA15827 | NOVARTIS PHARMACEUTICAL CORPORATION | YR | F | Y | 20120330 | MD | CANADA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248772 | 1019282827 | SS | ZOLEDRONOC ACID | 1 | INTRAVENOUS | UNK UKN, UNK | 021817 | ||||
| 8248772 | 1019282828 | C | ADALAT | 1 | 20 MG, QD | ||||||
| 8248772 | 1019282829 | C | NEXIUM | 1 | 40 MG, BID | ||||||
| 8248772 | 1019282826 | PS | ZOLEDRONOC ACID | 1 | INTRAVENOUS | 5/100 MG/ML PER YEAR | 021817 | ||||
| 8248772 | 1019282830 | C | ENERGIX | 2 | UNK |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8248772 | 1019282826 | OSTEOPOROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8248772 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 8248772 | OEDEMA PERIPHERAL |
| 8248772 | PAIN IN EXTREMITY |
| 8248772 | HYPOKINESIA |
| 8248772 | HEART RATE INCREASED |
| 8248772 | STRESS |
| 8248772 | PHLEBITIS |
| 8248772 | SYNOVIAL CYST |
| 8248772 | CYANOSIS |
| 8248772 | PAIN |
| 8248772 | MALAISE |
| 8248772 | PYREXIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8248772 | 1019282827 | 20120229 | |||
| 8248772 | 1019282826 | 20110223 |